Soluble Recombinant Hemagglutinin Protein of H1N1pdm09 Influenza Virus Elicits Cross-Protection Against a Lethal H5N1 Challenge in Mice
Currently, influenza vaccines are produced using embryonated chicken eggs. Recently, recombinant influenza vaccines have been developed as a potential alternative to egg-grown vaccines. In this study, we evaluated the efficacy of soluble recombinant hemagglutinin (HA) protein produced in human cell...
Main Authors: | Shinya Yamada, Atsuhiro Yasuhara, Yoshihiro Kawaoka |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2019-09-01
|
Series: | Frontiers in Microbiology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fmicb.2019.02031/full |
Similar Items
-
Isolation and Characterization of Human Monoclonal Antibodies That Recognize the Influenza A(H1N1)pdm09 Virus Hemagglutinin Receptor-Binding Site and Rarely Yield Escape Mutant Viruses
by: Atsuhiro Yasuhara, et al.
Published: (2018-11-01) -
The Marmoset as an Animal Model of Influenza: Infection With A(H1N1)pdm09 and Highly Pathogenic A(H5N1) Viruses via the Conventional or Tracheal Spray Route
by: Kiyoko Iwatsuki-Horimoto, et al.
Published: (2018-05-01) -
Comparison of the Pathogenicity in Mice of A(H1N1)pdm09 Viruses Isolated between 2009 and 2015 in Japan
by: Hiromichi Mitake, et al.
Published: (2020-01-01) -
Hemagglutinin 222 Variants in Pandemic (H1N1) 2009 Virus
by: Maria Beatrice Valli, et al.
Published: (2011-04-01) -
Yeast expressed recombinant Hemagglutinin protein of Novel H1N1 elicits neutralising antibodies in rabbits and mice
by: Athmaram TN, et al.
Published: (2011-11-01)